Ingevity Corporation (NYSE: NGVT) is a Basic Materials company (Chemicals - Specialty) with a market capitalization of $2.0B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Ingevity Corporation had a Maz Rating of 3.47 out of 5 (B+, Buy), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.29), above most of its sector; its weakest was Growth (1.64), below most of its sector. The other factors: Profitability 4.16 (above most of its sector); Valuation 1.74 (more expensive than most of its sector); Financial Health 1.66 (below most of its sector). The current rating is for members: log in to see it.
At $59.28, Ingevity Corporation trades at 33.6x trailing earnings, 1.8x sales and 32.5x book value, with an EV/EBITDA of 16.4. Over the last twelve months it generated about $1.1B of revenue and $60M of net income. It runs a gross margin of 42.0%, an operating margin of 22.4% and a net margin of 5.3%. It shows return on equity of 134.0%, return on invested capital of 15.4% and a free cash flow yield of 6.1%. On the balance sheet: a debt-to-equity ratio of 18.71 and a current ratio of 1.48. Over the past 52 weeks the share price ranged from $46.38 to $79.29, with a beta of 1.11.
Ingevity Corporation does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 10 Buy and 3 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.